Pamoja Capital
VC Fund
Luxembourg, Luxembourg
Pamoja Capital is a VC fund in Luxembourg focused on Health Care and Fitness. The Pamoja Capital Group is a private investment firm founded in 2006 by John McCall MacBain and his team following the sale of Trader Classified Media. Pamoja means “togetherness in Swahili.Pamoja Capital Group creates value through long-term, socially-responsible, global investments across a number of industry sectors, including education,life sciences, information technology, real estate and media and communications.The firm's investments span all stages of corporate growth, including seed and growth capital. The firm places special emphasis on investing in businesses with sustainable cash flow. Pamoja Capital Group believes that the experience of its managers in operating global businesses, combined with the long-term orientation of its financial resources, gives its portfolio companies a distinct competitive advantage.
- Total investments:
- 6
- Last investment:
- Lead investor:
- 33%
Last updated:
For AI agents: llms.txt
Industries Pamoja Capital invests in
Stages Pamoja Capital invests in
Countries Pamoja Capital invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Series B
- $5.1M–$115M
Investment Focus
Industry
- Health Care 4 (67%)
- Fitness 1 (17%)
- Medical 1 (17%)
- Wellness 1 (17%)
- Organic Food 1 (17%)
Stage
- Series B 3 (50%)
- Seed 1 (17%)
- Pre-Seed 1 (17%)
- Series C 1 (17%)
Country
- United States 3 (50%)
- Poland 1 (17%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
John H. McCall MacBain
Founder
|
Founder | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Mindgram is a science-based platform and mobile app for complete mental wellness. | $7.7M / Seed / Apr 04, 2022 | ||
| The Nue Co. was born after a trip to Copenhagen inspired them to create a supplement brand founded on two danish principles, simplicity and creativity.Their lab has over 20 years experience and is based in Cambridge, England. Rather than working with harsh, isolated vitamins they choose to work with powerful organic foods high in specificvitamins or minerals. Every ingredient they use is completely traceable and of the highest standard. They never add fillers of any type, making their blends potent and pure.They limit the use of plastic packaging and are focused on minimising their carbon footprint. | $25M / Series B / Jul 15, 2021 | ||
| Mindgram is a science-based platform and mobile app for complete mental wellness. | $2.2M / Pre-Seed / Apr 20, 2021 | ||
| Talaris Therapeutics is a operator of a biotechnology company engaged in the development of innovative cellular therapies. The company's proprietary allogeneic cell therapy product has shown to induce tolerance in recipients of solid organ transplants from unmatched and unrelated donors, enabling living donor kidney transplant recipients towean completely off immunosuppression one year after transplant. | $115M / Series B / Oct 06, 2020 | ||
| Vapogenix is a clinical-stage company developing a new class of non-narcotic analgesics for localized pain. It focuses on treating pain locally at its source their products are formulated volatile anesthetics currently unformulated volatile anesthetics are used only as general anesthetics, by inhalation. It was founded in 2006 and headquarteredin Houston, Texas. | $8.2M / Series C / Dec 08, 2016 | ||
| Vapogenix is a clinical-stage company developing a new class of non-narcotic analgesics for localized pain. It focuses on treating pain locally at its source their products are formulated volatile anesthetics currently unformulated volatile anesthetics are used only as general anesthetics, by inhalation. It was founded in 2006 and headquarteredin Houston, Texas. | $5.1M / Series B / Mar 05, 2015 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Featured in Investor Lists
Recommended lists
FAQ
What does Pamoja Capital invest in?
Pamoja Capital invests primarily in Health Care, Fitness and Medical startups, most often at Series B and Seed stage. Most of the 6 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What round sizes does Pamoja Capital invest in?
Pamoja Capital typically joins rounds of $5.1M–$115M at Series B. These are whole funding-round sizes, not Pamoja Capital's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds Pamoja Capital took part in.
How do I contact Pamoja Capital?
Public channels for Pamoja Capital include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Pamoja Capital?
The team at Pamoja Capital includes John H. McCall MacBain (Founder). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Nov 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
